Naturland Holding PLC Logo

Naturland Holding PLC

A Hungarian company providing full-scale pharmaceutical manufacturing from R&D to sales.

NATUR | BUD

Overview

Corporate Details

ISIN(s):
HU0000199740
LEI:
Country:
United Kingdom
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Naturland Holding PLC is a Hungarian company engaged in the full scale of pharmaceutical manufacturing. Its activities encompass research and development, product licensing, production, and sales of pharmaceutical products. The company operates through its subsidiaries to develop and bring its products to market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 12:04
Declaration of Voting Results & Voting Rights Announcements
Szavazati jogok, alaptőke
Hungarian 148.4 KB
2025-09-30 12:33
Declaration of Voting Results & Voting Rights Announcements
Szavazati jogok, alaptőke
Hungarian 148.3 KB
2025-09-25 17:34
Interim Report
Féléves jelentés
Hungarian 4.7 MB
2025-09-01 14:33
Declaration of Voting Results & Voting Rights Announcements
Szavazati jogok, alaptőke
Hungarian 148.4 KB

Automate Your Workflow. Get a real-time feed of all Naturland Holding PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Naturland Holding PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Naturland Holding PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Liquidia Corp Logo
Develops inhaled therapies for rare cardiopulmonary diseases using proprietary PRINT® technology.
United States of America
LQDA
LISATA THERAPEUTICS, INC. Logo
Oncology firm with a platform for more effective, targeted delivery of anti-cancer drugs.
United States of America
LSTA
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Logo
Developing novel PP2A inhibitors to enhance cancer therapies and overcome treatment resistance.
United States of America
LIXT
Longeveron Inc. Logo
Develops cell therapies for Alzheimer's, aging frailty, and rare infant heart defects.
United States of America
LGVN
Lonza Group AG Logo
A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.
Switzerland
LONN
Lyell Immunopharma, Inc. Logo
Develops durable CAR T-cell therapies for solid tumors & blood cancers by reprogramming T-cells.
United States of America
LYEL
Lyra Therapeutics, Inc. Logo
Developing localized, long-acting therapies for chronic rhinosinusitis (CRS).
United States of America
LYRA
Lytix Biopharma AS Logo
Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.
Norway
LYTIX
MaaT Pharma Logo
Developing gut microbiome therapies to improve survival for cancer patients.
France
MAAT
Mabion S.A. Logo
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
Poland
MAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.